Karen L. Zaderej - May 16, 2025 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Stock symbol
EYPT
Transactions as of
May 16, 2025
Transactions value $
$59,000
Form type
4
Date filed
5/19/2025, 04:06 PM
Previous filing
May 15, 2025
Next filing
Jul 11, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zaderej Karen L. Director C/O EYEPOINT PHARMACEUTICALS, INC., 480 PLEASANT STREET, WATERTOWN /s/ Ron Honig, Attorney-in-Fact 2025-05-19 0001530968

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Purchase $29.1K +5K +18.87% $5.81 31.5K May 16, 2025 Direct
transaction EYPT Common Stock Purchase $30K +5K +15.87% $5.99 36.5K May 19, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.